Mitchell Finer
Overview
Explore the profile of Mitchell Finer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al.
JCI Insight
. 2019 Jul;
4(13).
PMID: 31292299
Oncolytic viruses induce local tumor destruction and inflammation. Whether virotherapy can also overcome immunosuppression in noninfected tumor areas is under debate. To address this question, we have explored immunologic effects...
2.
Negre O, Bartholomae C, Beuzard Y, Cavazzana M, Christiansen L, Courne C, et al.
Curr Gene Ther
. 2014 Nov;
15(1):64-81.
PMID: 25429463
A previously published clinical trial demonstrated the benefit of autologous CD34(+) cells transduced with a selfinactivating lentiviral vector (HPV569) containing an engineered β-globin gene (β(A-T87Q)-globin) in a subject with β...
3.
Hanna Jr M, Hoover Jr H, Pinedo H, Finer M
Hum Vaccin
. 2006 Oct;
2(4):185-91.
PMID: 17012885
In the area of cancer treatment, immunotherapy with vaccines has suffered in the last five years, due to many clinical trial failures. One must keep in mind however, that many...
4.
Sheu E, Rothman S, German M, Wang X, Finer M, McMahon B
Curr Opin Mol Ther
. 2003 Sep;
5(4):420-7.
PMID: 14513686
Gene delivery represents a revolutionary therapeutic approach with the potential for sustained protein production by the human body, leading to a convenient and effective method for systemic delivery of protein...
5.
Hokanson C, Dora E, Donahue B, Rivkin M, Finer M, Mendez M
Hum Gene Ther
. 2003 Mar;
14(4):329-39.
PMID: 12659674
Adenoviral vectors are widely used to express transgenes in vitro and in vivo. A major obstacle to the generation of adenoviral vectors is the manipulation of the large (35 kb)...